Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition: a Tissue Biopsy Based imaGing Study
Clinical trial NCT05921123 · UNKNOWN
Trial details
- NCT number
- NCT05921123
- Sponsor
- University Hospital, Brest
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-25
- Primary completion
- 2024-11-25
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.